Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
PROT# TOG201: A Phase II Study of Tesetaxel Administered at a Flat Dose Once Every 21 Days as Second-Line Therapy to Subjects with Advanced Gastric Cancer
Mulcahy, Mary Frances
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
3/25/10
→
12/25/17
Funding
Genta Incorporated
(TOG201)
View all
View less